Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Completed 3

Sponsor Class

NETWORK 3OTHER 2

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

CNS 3Sarcoma 2

Conditions

Lymphoma 9Breast Neoplasms 9Squamous Cell Carcinoma of Head and Neck 6Head and Neck Neoplasms 6Lymphoma, Follicular 5Neuroblastoma 4Central Nervous System Neoplasms 4Sarcoma 3Melanoma 3Lymphoma, Large B-Cell, Diffuse 3Brain Neoplasms 3Unspecified Adult Solid Tumor, Protocol Specific 2Salivary Gland Neoplasms 2Lymphoma, Large-Cell, Immunoblastic 2Lung Neoplasms 2Kidney Neoplasms 2Hodgkin Disease 2Gliosarcoma 2Glioblastoma 2Carcinoma, Non-Small-Cell Lung 2Breast Neoplasms, Male 2Wilms Tumor 1Testicular Neoplasms 1Testicular Germ Cell Tumor 1Teratoma, Testicular 1Teratoma 1Sarcoma, Kaposi 1Rhabdoid Tumor 1Rectal Neoplasms 1Prostatic Neoplasms 1

Interventions

Radiotherapy 18Temozolomide 11Vincristine 10Filgrastim 9Etoposide 9Granulocyte Colony-Stimulating Factor 8Carboplatin 8Cyclophosphamide 7Radiotherapy, Intensity-Modulated 6Cisplatin 6Radiotherapy, Conformal 5Radiosurgery 5Peripheral Blood Stem Cell Transplantation 5Lomustine 5etoposide phosphate 4Thiotepa 3Immunohistochemistry 3Chemotherapy, Adjuvant 3Bevacizumab 3sargramostim 2Topotecan 2Psychiatric Rehabilitation 2Proton Therapy 2Procarbazine 2Microarray Analysis 2Mesna 2Mental Status and Dementia Tests 2Memantine 2In Situ Hybridization, Fluorescence 2Ifosfamide 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
NETWORK × Brain Neoplasms × Immunohistochemistry × Clear all
NCT00387400 2023-08-04

Temozolomide + Everolimus in Newly Diagnosed, Recurrent, or Progressive Malignant Glioblastoma Multiforme

Canadian Cancer Trials Group

Phase 1 Completed
32 enrolled
CNSSarcoma

Brain Neoplasms, Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma

NCT01585389 2016-05-18

Studying Gene Expression and Location in Samples From Patients With Brain Tumors

Children's Oncology Group

Completed
10 enrolled
CNS

Brain Neoplasms, Central Nervous System Neoplasms

NCT00424060 2012-09-24

Epothilone ZK-219477 in Treating Patients With Recurrent Glioblastoma

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Completed
38 enrolled
CNSSarcoma

Brain Neoplasms, Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡